How effective is Aplenzin for Major Depression? (a real world drug study)
Summary:
Overall ratings: 3.3/5 Long term ratings: 3.2/5
This is a phase IV clinical study of how effective Aplenzin (bupropion hydrobromide) is for Major depression and for what kind of people. The study is created by eHealthMe from 6 Aplenzin users and is updated continuously.
What is Aplenzin?
Aplenzin has active ingredients of bupropion hydrobromide. It is often used in depression. eHealthMe is studying from 396 Aplenzin users. Check the latest studies of Aplenzin.
What is Major depression?
Major depression (a mood state that goes well beyond temporarily feeling sad or blue. it is a serious medical illness that affects one's thoughts, feelings) is found to be associated with 804 drugs and 1,475 conditions by eHealthMe. Check the latest studies of Major depression.
6 people are studied for taking Aplenzin in Major depression
Overall effectiveness (number of people):
Long term (1+ years) effectiveness (number of people):
Aplenzin effectiveness for Major depression (number of people):
Overall:
- not at all: 0
- somewhat: 2
- moderate: 1
- high: 2
- very high: 1
Long Term:
- not at all: 0
- somewhat: 2
- moderate: 1
- high: 1
- very high: 1
Gender of people who take Aplenzin for Major depression *:
- female: 83.33 %
- male: 16.67 %
Age of people who take Aplenzin for Major depression *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 16.67 %
- 30-39: 16.67 %
- 40-49: 50.0 %
- 50-59: 16.67 %
- 60+: 0.0 %
Who find Aplenzin more effective for Major Depression?
Gender of people who take Aplenzin for Major depression *:
- female: 66.67 %
- male: 33.33 %
Age of people who take Aplenzin for Major depression *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 33.33 %
- 40-49: 66.67 %
- 50-59: 0.0 %
- 60+: 0.0 %
* Approximation only. Some reports may have incomplete information.
Do you take Aplenzin?
- You can start a phase IV clinical trial to monitor Aplenzin safety and effectiveness.How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Related studies
Alternative drugs to, pros and cons of:
- Aplenzin (396 reports)
Treatments, associated drugs and conditions:
- Major depression (44,979 reports)
How the study uses the data?
The study is based on bupropion hydrobromide (the active ingredients of Aplenzin) and Aplenzin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study neither.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Marinol vs. Talwin Nx, side effect and effectiveness comparison - now
- Combivent and White Blood Cell Count Decreased for Women aged 60+ - 7 seconds ago
- Could Claritin cause Ventricular Arrhythmia? - 9 seconds ago
- Drug interactions of Oxybutynin and Digoxin - 10 seconds ago
- Could Lotrel cause Renal Cyst? - 10 seconds ago
- Sertraline and Thrombocytopenia Aggravated for Women aged 30-39 - 19 seconds ago
- Duodenitis and drugs of ingredients of acetaminophen; propoxyphene napsylate - 23 seconds ago
- Pain and drugs of ingredients of deflazacort - 25 seconds ago
- B Complex Vitamin vs. Lutein, side effect and effectiveness comparison - 25 seconds ago
- Could Timolol cause Haematemesis? - 26 seconds ago